{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:27:07Z","timestamp":1777865227705,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R42AI126971"],"award-info":[{"award-number":["R42AI126971"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21572281"],"award-info":[{"award-number":["21572281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21877132"],"award-info":[{"award-number":["21877132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2017A020211003"],"award-info":[{"award-number":["2017A020211003"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010843","name":"Guangzhou Science, Technology and Innovation Commission","doi-asserted-by":"publisher","award":["201704030087"],"award-info":[{"award-number":["201704030087"]}],"id":[{"id":"10.13039\/501100010843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejmech.2020.112595","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T17:25:49Z","timestamp":1594574749000},"page":"112595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Development of coumarine derivatives as potent anti-filovirus entry inhibitors targeting viral glycoprotein"],"prefix":"10.1016","volume":"204","author":[{"given":"Yinyi","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaokeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112595_bib1","series-title":"Ebola Treatments Approved for Compassionate Use in Current Outbreak","author":"Organization","year":"2018"},{"key":"10.1016\/j.ejmech.2020.112595_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112595_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112595_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112595_bib5","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S1473-3099(18)30397-9","article-title":"Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study","volume":"18","author":"Sivapalasingam","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112595_bib6","first-page":"460","article-title":"Ebola outbreak prompts experimental drug rollout","volume":"17","author":"Mullard","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112595_bib7","series-title":"Ebola Virus Disease \u2013 Democratic Republic of the Congo","author":"Organization","year":"2019"},{"key":"10.1016\/j.ejmech.2020.112595_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00831-17","article-title":"Enfuvirtide (T20)-Based lipopeptide is a potent HIV-1 cell fusion inhibitor: implications for viral entry and inhibition","volume":"91","author":"Ding","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2020.112595_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus glycoprotein structure and mechanism of entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol."},{"key":"10.1016\/j.ejmech.2020.112595_bib10","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/JVI.79.8.4793-4805.2005","article-title":"Comprehensive analysis of ebola virus GP1 in viral entry","volume":"79","author":"Manicassamy","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2020.112595_bib11","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1128\/JVI.03689-14","article-title":"Role of EXT1 and glycosaminoglycans in the early stage of filovirus entry","volume":"89","author":"O\u2019Hearn","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2020.112595_bib12","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1128\/JVI.01621-12","article-title":"Filoviruses utilize glycosaminoglycans for their attachment to target cells","volume":"87","author":"Salvador","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2020.112595_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/JVI.05708-11","article-title":"Cathepsin cleavage potentiates the ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change","volume":"86","author":"Brecher","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2020.112595_bib14","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112595_bib15","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2020.112595_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112595_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"Cote","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112595_bib18","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.cell.2016.05.022","article-title":"Structural insights into the niemann-pick C1 (NPC1)-mediated cholesterol transfer and ebola infection","volume":"165","author":"Gong","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2020.112595_bib19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cell.2015.12.044","article-title":"Ebola viral glycoprotein bound to its endosomal receptor niemann-pick C1","volume":"164","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2020.112595_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.antiviral.2017.06.015","article-title":"Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor","volume":"145","author":"Cheng","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2020.112595_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2018.07.003","article-title":"Repurposing potential of 1st generation H-1-specific antihistamines as anti-filovirus therapeutics","volume":"157","author":"Schafer","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2020.112595_bib22","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1021\/acs.jmedchem.8b01328","article-title":"Structure-based in silico screening identifies a potent ebolavirus inhibitor from a traditional Chinese medicine library","volume":"62","author":"Shaikh","year":"2019","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420305675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420305675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:59:32Z","timestamp":1777528772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420305675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":22,"alternative-id":["S0223523420305675"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112595","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of coumarine derivatives as potent anti-filovirus entry inhibitors targeting viral glycoprotein","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112595"}}